Semaglutide: Transforming Challenges into Opportunities for Weight Management

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist initially developed for the treating type 2 diabetes, has garnered attention because of its remarkable efficacy in promoting ...